Angiogenin reduces immune inflammation via inhibition of tank-binding kinase 1 expression in human corneal fibroblast cells

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Lee, Seung Hoon ^a   Kim, Kyoung Woo ^a   Min, Kyong Mi ^b   Kim, Kyu Wan ^b   Chang, Soo Ik ^b   Kim, Jae Chan ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOTRANSFERASE; TANK BINDING KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; PANCREATIC RIBONUCLEASE; PROTEIN SERINE THREONINE KINASE; TBK1 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA; CULTURE MEDIUM; DOWN REGULATION; ENZYME INHIBITION; EYE INFLAMMATION; FIBROBLAST; GENE EXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN EXPRESSION; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM;

CELLS, CULTURED; CHEMOKINE CCL2; CORNEA; FIBROBLASTS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; RIBONUCLEASE, PANCREATIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899962763     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/861435     Document Type: Article

References (72)

1. Mintz R., Feller E., Bahr R. L., Shah S. A., Ocular manifestations of inflammatory bowel disease. Inflammatory Bowel Diseases 2004 10 2 135 139 2-s2.0-1542725068 10.1097/00054725-200403000-00012 (Pubitemid 38332174)
2. Rothova A., Suttorp-van Schulten M. S. A., Frits Treffers W., Kijlstra A., Causes and frequency of blindness in patients with intraocular inflammatory disease. British Journal of Ophthalmology 1996 80 4 332 336 2-s2.0-0029913597 (Pubitemid 26113585)
3. Zoukhri D., Effect of inflammation on lacrimal gland function. Experimental Eye Research 2006 82 5 885 898 2-s2.0-31744441241 10.1016/j.exer.2005.10.018 (Pubitemid 43173444)
4. Wilson S. E., Mohan R. R., Mohan R. R., Ambrósio R. Jr., Hong J., Lee J., The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Progress in Retinal and Eye Research 2001 20 5 625 637 2-s2.0-0034928852 10.1016/S1350-9462(01)00008-8 (Pubitemid 32695343)
5. Na K. S., Mok J. W., Kim J. Y., Rho C. R., Joo C. K., Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Investigative Ophthalmology & Visual Science 2012 53 9 5443 5450 10.1167/iovs.11-9417
6. Valentincic N. V., de Groot-Mijnes J. D. F., Kraut A., Korosec P., Hawlina M., Rothova A., Intraocular and serum cytokine profiles in patients with intermediate uveitis. Molecular Vision 2011 17 2003 2010 2-s2.0-79960728249
7. VanDerMeid K. R., Su S. P., Ward K. W., Zhang J.-Z., Correlation of tear inflammatory cytokines and matrix metalloproteinases with four dry eye diagnostic tests. Investigative Ophthalmology & Visual Science 2012 53 3 1512 1518 2-s2.0-84860580697
8. King W. J., Comer R. M., Hudde T., Larkin D. F. P., George A. J. T., Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 2000 70 8 1225 1233 2-s2.0-0034721753
9. Mahajan V. B., Wei C., McDonnell P. J. III, Microarray analysis of corneal fibroblast gene expression after interleukin-1 treatment. Investigative Ophthalmology and Visual Science 2002 43 7 2143 2151 2-s2.0-0036297792 (Pubitemid 34700640)
10. Xi X., McMillan D. H., Lehmann G. M., Sime P. J., Libby R. T., Huxlin K. R., Feldon S. E., Phipps R. P., Ocular fibroblast diversity: implications for inflammation and ocular wound healing. Investigative Ophthalmology & Visual Science 2011 52 7 4859 4865 2-s2.0-80052382837
11. Streilein J. W., Dana M. R., Ksander B. R., Immunity causing blindness: five different paths to herpes stromal keratitis. Immunology Today 1997 18 9 443 449 2-s2.0-0030770508 10.1016/S0167-5699(97)01114-6 (Pubitemid 27381987)
12. Liu Y., Kimura K., Yanai R., Chikama T.-I., Nishida T., Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C). Investigative Ophthalmology and Visual Science 2008 49 8 3336 3344 2-s2.0-49049108736 10.1167/iovs.07-0972
13. Fini M. E., Keratocyte and fibroblast phenotypes in the repairing cornea. Progress in Retinal and Eye Research 1999 18 4 529 551 2-s2.0-0033024366 10.1016/S1350-9462(98)00033-0 (Pubitemid 29126966)
14. Daniels J. T., Geerling G., Alexander R. A., Murphy G., Khaw P. T., Saarialho-Kere U., Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Experimental Eye Research 2003 77 6 653 664 2-s2.0-0242426583 10.1016/j.exer.2003.08.010 (Pubitemid 37373579)
15. Smith R. S., Smith T. J., Blieden T. M., Phipps R. P., Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. The American Journal of Pathology 1997 151 2 317 322 2-s2.0-0031201054
16. Maertzdorf J., Osterhaus A. D. M. E., Verjans G. M. G. M., IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. Journal of Immunology 2002 169 10 5897 5903 2-s2.0-0037111404 (Pubitemid 35291695)
17. Pfister R. R., Hadclox J. L., Sommers C. I., Injection of chemoattractants into normal cornea: a model of inflammation after alkali injury. Investigative Ophthalmology and Visual Science 1998 39 9 1744 1750 2-s2.0-0031859054 (Pubitemid 28361339)
18. Hayden M. S., Ghosh S., Shared principles in NF- B signaling. Cell 2008 132 3 344 362 2-s2.0-38849199203 10.1016/j.cell.2008.01.020 (Pubitemid 351192002)
19. Miyamoto S., Maki M., Schmitt M. J., Hatanaka M., Verma I. M., Tumor necrosis factor α -induced phosphorylation of I B α is a signal for its degradation but not dissociation from NF- B. Proceedings of the National Academy of Sciences of the United States of America 1994 91 26 12740 12744 2-s2.0-0028557348 10.1073/pnas.91.26.12740
20. Kravchenko V. V., Mathison J. C., Schwamborn K., Mercurio F., Ulevitch R. J., IKKi/IKK ε plays a key role in integrating signals induced by pro-inflammatory stimuli. Journal of Biological Chemistry 2003 278 29 26612 26619 2-s2.0-0038374178 10.1074/jbc.M303001200 (Pubitemid 36876806)
21. Pomerantz J. L., Baltimore D., NF- B activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO Journal 1999 18 23 6694 6704 2-s2.0-0033485542
22. Reilly S. M., Chiang S. H., Decker S. J., Chang L., Uhm M., Larsen M. J., Rubin J. R., Mowers J., White N. M., Hochberg I., Downes M., Yu R. T., Liddle C., Evans R. M., Oh D., Li P., Olefsky J. M., Saltiel A. R., An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice. Nature Medicine 2013 19 3 313 321 10.1038/nm.3082
23. Bräuer L., Paulsen F. P., Tear film and ocular surface surfactants. Journal of Epithelial Biology and Pharmacology 2008 1 62 67
24. Sack R. A., Conradi L., Krumholz D., Beaton A., Sathe S., Morris C., Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Investigative Ophthalmology and Visual Science 2005 46 4 1228 1238 2-s2.0-18244395597 10.1167/iovs.04-0760 (Pubitemid 41685857)
25. Xu Z.-P., Monti D. M., Hu G.-F., Angiogenin activates human umbilical artery smooth muscle cells. Biochemical and Biophysical Research Communications 2001 285 4 909 914 2-s2.0-0034817123 10.1006/bbrc.2001.5255 (Pubitemid 32918022)
26. Hartmann A., Kunz M., Köstlin S., Gillitzer R., Toksoy A., Bröcker E.-B., Klein C. E., Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Research 1999 59 7 1578 1583 2-s2.0-0033119037 (Pubitemid 29160129)
27. Etoh T., Shibuta K., Barnard G. F., Kitano S., Mori M., Angiogenin expression in human colorectal cancer: the role of focal macrophage infiltration. Clinical Cancer Research 2000 6 9 3545 3551 2-s2.0-0033822949
28. Oikonomou K. A., Kapsoritakis A. N., Kapsoritaki A. I., Manolakis A. C., Tiaka E. K., Tsiopoulos F. D., Tsiompanidis I. A., Potamianos S. P., Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflammatory Bowel Diseases 2011 17 4 963 970 2-s2.0-79952481259 10.1002/ibd.21410
29. Osorio D. S., Antunes A., Ramos M. J., Structural and functional implications of positive selection at the primate angiogenin gene. BMC Evolutionary Biology 2007 7, article 167 2-s2.0-38149066606 10.1186/1471-2148-7- 167
30. Hooper L. V., Stappenbeck T. S., Hong C. V., Gordon J. I., Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunology 2003 4 3 269 273 2-s2.0-0037340434 10.1038/ni888 (Pubitemid 36322137)
31. Srisa-Art M., Kang D.-K., Hong J., Park H., Leatherbarrow R. J., Edel J. B., Chang S.-I., de Mello A. J., Analysis of protein-protein interactions by using droplet-based microfluidics. ChemBioChem 2009 10 10 1605 1611 2-s2.0-70349558316 10.1002/cbic.200800841
32. Widłocha A., Following angiogenin during angiogenesis: a journey from the cell surface to the nucleolus. Archivum Immunologiae et Therapiae Experimentalis 1999 47 5 299 305 2-s2.0-0033256881
33. Kishimoto K., Liu S., Tsuji T., Olson K. A., Hu G.-F., Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005 24 3 445 456 2-s2.0-13244264730 10.1038/sj.onc.1208223 (Pubitemid 40188592)
34. Wei S., Gao X., Du J., Su J., Xu Z., Angiogenin enhances cell migration by regulating stress fiber assembly and focal adhesion dynamics. PLoS ONE 2011 6 12 2-s2.0-83355170592 10.1371/journal.pone.0028797 e28797
35. Fett J. W., Strydom D. J., Lobb R. R., Alderman E. M., Lemuel Bethune J., Riordan J. F., Vallee B. L., Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985 24 20 5480 5486 2-s2.0-0022399773 (Pubitemid 16228828)
36. Riordan J. F., Vallee B. L., Human angiogenin, an organogenic protein. British Journal of Cancer 1988 57 6 587 590 2-s2.0-0023937146
37. Yoshioka N., Wang L., Kishimoto K., Tsuji T., Hu G.-F., A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 2006 103 39 14519 14524 2-s2.0-33749251639 10.1073/pnas.0606708103 (Pubitemid 44484782)
38. Nilsson U. W., Abrahamsson A., Dabrosin C., Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo. Clinical Cancer Research 2010 16 14 3659 3669 2-s2.0-77954743919 10.1158/1078-0432.CCR-10-0501
39. Li S., Ibaragi S., Hu G.-F., Angiogenin as a molecular target for the treatment of prostate cancer. Current Cancer Therapy Reviews 2011 7 2 83 90 2-s2.0-79953784016
40. Lioté F., Champy R., Moenner M., Boval-Boizard B., Badet J., Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clinical and Experimental Immunology 2003 132 1 163 168 2-s2.0-0037386222 10.1046/j.1365-2249.2003.02117.x (Pubitemid 36422602)
41. Koutroubakis I. E., Xidakis C., Karmiris K., Sfiridaki A., Kandidaki E., Kouroumalis E. A., Serum angiogenin in inflammatory bowel disease. Digestive Diseases and Sciences 2004 49 11-12 1758 1762 2-s2.0-13644257688 10.1007/s10620-004-9565-4 (Pubitemid 40228533)
42. Hooper L. V., Stappenbeck T. S., Hong C. V., Gordon J. I., Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nature Immunology 2003 4 3 269 273 2-s2.0-0037340434 10.1038/ni888 (Pubitemid 36322137)
43. Xie X.-H., Zang N., Li S.-M., Wang L.-J., Deng Y., He Y., Yang X.-Q., Liu E.-M., Resveratrol inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. Inflammation 2012 35 4 1392 1401 2-s2.0-84857671057 10.1007/s10753-012-9452-7
44. Marchlik E., Thakker P., Carlson T., Jiang Z., Ryan M., Marusic S., Goutagny N., Kuang W., Askew G. R., Roberts V., Benoit S., Zhou T., Ling V., Pfeifer R., Stedman N., Fitzgerald K. A., Lin L.-L., Hall J. P., Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality. Journal of Leukocyte Biology 2010 88 6 1171 1180 2-s2.0-78649737887 10.1189/jlb.0210071
45. Yu T., Yi Y. S., Yang Y., Oh J., Jeong D., Cho J. Y., The pivotal role of TBK1 in inflammatory responses mediated by macrophages. Mediators of Inflammation 2012 2012 8 979105 10.1155/2012/979105
46. Hammaker D., Boyle D. L., Firestein G. S., Synoviocyte innate immune responses: tank-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis. Rheumatology 2012 51 4 610 618 2-s2.0-84858689774 10.1093/rheumatology/ker154
47. Migita K., Nakamura T., TBK1: a potential therapeutic target in RA. Rheumatology 2012 51 4 588 589 2-s2.0-84858685179 10.1093/rheumatology/ker207
48. Zhu J., Yong W., Wu X., Yu Y., lv J., Liu C., Mao X., Zhu Y., Xu K., Han X., Liu C., Anti-inflammatory effect of resveratrol on TNF- α -induced MCP-1 expression in adipocytes. Biochemical and Biophysical Research Communications 2008 369 2 471 477 2-s2.0-40849106331 10.1016/j.bbrc.2008.02.034
49. Deshmane S. L., Kremlev S., Amini S., Sawaya B. E., Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of Interferon and Cytokine Research 2009 29 6 313 325 2-s2.0-66149172257 10.1089/jir.2008.0027
50. Ooi K. G.-J., Galatowicz G., Calder V. L., Lightman S. L., Cytokines and chemokines in uveitis-is there a correlation with clinical phenotype? Clinical Medicine and Research 2006 4 4 294 309 2-s2.0-33846531775 (Pubitemid 46166379)
51. Ghasemi H., Ghazanfari T., Yaraee R., Faghihzadeh S., Hassan Z. M., Roles of IL-8 in ocular inflammations: a review. Ocular Immunology and Inflammation 2011 19 6 401 412 2-s2.0-81855224889 10.3109/09273948.2011.618902
52. Lema I., Sobrino T., Durán J. A., Brea D., Díez-Feijoo E., Subclinical keratoconus and inflammatory molecules from tears. British Journal of Ophthalmology 2009 93 6 820 824 2-s2.0-66749171362 10.1136/bjo.2008.144253
53. Tuaillon N., Shen D. F., Berger R. B., Lu B., Rollins B. J., Chan C.-C., MCP-1 expression in endotoxin-induced uveitis. Investigative Ophthalmology and Visual Science 2002 43 5 1493 1498 2-s2.0-0036242464 (Pubitemid 34462649)
54. Rojas M., Zhang W., Lee D. L., Romero M. J., Nguyen D. T., Al-Shabrawey M., Tsai N.-T., Liou G. I., Brands M. W., Caldwell R. W., Caldwell R. B., Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Investigative Ophthalmology and Visual Science 2010 51 3 1709 1718 2-s2.0-77949901365 10.1167/iovs.09-3375
55. Gabay C., Interleukin-6 and chronic inflammation. Arthritis Research and Therapy 2006 8 supplement 2, article S3 1 6 2-s2.0-33748121115 10.1186/ar1917
56. Akira S., Taga T., Kishimoto T., Interleukin-6 in biology and medicine. Advances in Immunology 1993 54 1 78 2-s2.0-0027421831 (Pubitemid 23289250)
57. Kishimoto T., Interleukin-6: from basic science to medicine-40 years in immunology. Annual Review of Immunology 2005 23 1 21 2-s2.0-17644368573 10.1146/annurev.immunol.23.021704.115806 (Pubitemid 40563163)
58. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K., Essential involvement of interleukin-8 (IL-8) in acute inflammation. Journal of Leukocyte Biology 1994 56 5 559 564 2-s2.0-0027988669 (Pubitemid 24348812)
59. Izzo R. S., Witkon K., Chen A. I., Hadjiyane C., Weinstein M. I., Pellecchia C., Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scandinavian Journal of Gastroenterology 1993 28 4 296 300 2-s2.0-0027582292
60. Gibson P., Rosella O., Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 1995 37 4 536 543 2-s2.0-0028847255
61. Conti P., DiGioacchino M., MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy and Asthma Proceedings 2001 22 3 133 137 2-s2.0-0035351230
62. Viedt C., Dechend R., Fei J., Hänsch G. M., Kreuzer J., Orth S. R., MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor- B and activating protein-1. Journal of the American Society of Nephrology 2002 13 6 1534 1547 2-s2.0-0036014937 10.1097/01.ASN.0000015609.31253.7F (Pubitemid 34579243)
63. Marie C., Pitton C., Fitting C., Cavaillon J.-M., Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGF β) of interleukin-8 production by LPS- and/or TNF α -activated human polymorphonuclear cells. Mediators of Inflammation 1996 5 5 334 340 2-s2.0-0029905581 (Pubitemid 26395399)
64. Lee S. W., Hong Y. S., Chun C. M., Moon J. D., Kim S. J., Jung I. C., Yoon Y. H., Lee B. A., Moon S. W., Choi S. H., Moon C. K., Anti-inflammatory effects of IL-4 and IL-10 on human polymorphonuclear leukocytes. Journal of Korean medical science 2002 17 1 7 14 2-s2.0-0036480713
65. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.-G., Te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J. E., Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. Journal of Experimental Medicine 1991 174 4 915 924 2-s2.0-0026000892
66. Mak T. W., Yeh W. C., Signaling for survival and apoptosis in the immune system. Arthritis Research 2002 4 supplement 3 S243 S252 10.1186/ar569
67. Blackwell T. S., Christman J. W., The role of nuclear factor- B in cytokine gene regulation. American Journal of Respiratory Cell and Molecular Biology 1997 17 1 3 9 2-s2.0-0031183766 (Pubitemid 127500814)
68. Muñoz M. C., Giani J. F., Mayer M. A., Toblli J. E., Turyn D., Dominici F. P., TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance. Journal of Endocrinology 2009 201 2 185 197 2-s2.0-67650723456 10.1677/JOE-08-0276
69. Hart L. A., Krishnan V. L., Adcock I. M., Barnes P. J., Chung K. F., Activation and localization of transcription factor, nuclear factor- B, in asthma. American Journal of Respiratory and Critical Care Medicine 1998 158 5 1585 1592 2-s2.0-0031731150
70. Tak P. P., Firestein G. S., NF- B: a key role in inflammatory diseases. Journal of Clinical Investigation 2001 107 1 7 11 2-s2.0-0034746919
71. Collins T., Cybulsky M. I., NF- B: pivotal mediator or innocent bystander in atherogenesis? Journal of Clinical Investigation 2001 107 3 255 264 2-s2.0-0034746311 (Pubitemid 32157955)
72. Asahara H., Asanuma M., Ogawa N., Nishibayashi S., Inoue H., High DNA-binding activity of transcription factor NF- B in synovial membranes of patients with rheumatoid arthritis. Biochemistry and Molecular Biology International 1995 37 5 827 832 2-s2.0-0029552889 (Pubitemid 26177939)